Hey guys how you doing this is Rich from Rich to Delive and I got a special pick for you guys. I love to bring you guys picks. I love to bring them to you first. I knowvo. I and oh this company is on fire. I knowvo shares rally after biotech says human trials of coronavirus vaccine will start in April. This is huge news for Iovo shares of this is from Market Watch by Sierra Linne shares of I knowvo pharmaceuticals which you guys can see right up here. Right there. You can see they're up 69% and even after market they're still going up 9.5% after market at $8.16 with up 69% to $7.45. I thought about buying it. I didn't want to chase it and it exploded and it's going even higher because of the big news shares of I knowvo pharmaceuticals ink rallyed more than 16% on Tuesday. About 69% it was up 16% at the time of this article after the company said it accelerated the timeline for development of a vaccine to treat the coronavirus COVID-19 and expects to start human trials in the United States next month. Huge news breaking news the stock finished up 69% at $7.45 is now at $8.16 and up 9.53% at the stock I know has more than doubled in three months as expectations for the company's vaccine called I know-4800 have grown and as the virus has spread to more than 91,000 people worldwide and cause more than 3,100 deaths. Plymouth meaning Pennsylvania based Iovo in Inovio specializes in developing DNA vaccines and has created products to treat 15 indications. It is only the only company to have a face to vaccine for the coronavirus that caused middle east respiratory syndrome or MERS. The company was called on to help during the 2016 Zika outbreak and the Ebola outbreak in 2014. These guys need to be on full alert. I knowvo chief executive doctor J. Joseph Kim told the US coronavirus task force meeting at the White House on Monday that the company designed I know-4800 on January 10 in three hours after the publication of the genetic sequence of the virus for daily coverage on Corona, COVID, dash 19, Pollarature boy were breaking the news every single day. We immediately began clinical testing and small scale manufacturing and have already shared robust, public data with our public and private partners. Kim said in a statement, we plan to begin human clinical trials in the US in April and soon thereafter in China and South Korea where the outbreak is impacting the most people. This is why the stock is screaming. Maxim analyst Jason McCarthy PhD said in Iovo likely has the best vaccine option for the new illness. The speed with which it developed INO-4800 is demonstration of the versatility and speed with which an OVO can respond to an emergency situation. The company is consistently the recipient of non-deludive grant funding for its infectious disease vaccine for the coalition of epidemic, preparedness, innovations, CEPI. He wrote in a note to clients. In February, it was awarded up to 9 million for a COVID-19 vaccine. It has previously received up to 56 million for CEPI grants for MERS and Zika. In OVO is expecting to deliver 1 million doses of vaccine by your end using its existing resources but will need additional resources to scale up to provide further amounts. The company has finalized the design for human clinical trials and has developed large-scale manufacturing plans. This is so big. The stock is now up 10% post-market. It's at 8.15. It is flying. Wow. The company has finalized the design for human clinical trials and has developed large-scale manufacturing plans. It is planning to launch trials in the US in 30 healthy volunteers and expects to publish the first results by fall. In November, in OVO posted a net loss of 23 million or 25 cents a share in the third quarter of 2019 after a net loss of 25 million or 27 cents a share in the year earlier period. But nobody cares because they're finding potential at cure. For Americans, this is huge. Most of their losses revenue came to 867 million down from 2 million in the year earlier period. 867 revenue. 867,000 revenue. Shares of 4 other companies seeking to develop a COVID-19 vaccine were lower Tuesday, and the stock exploded. Doing a sneak attack, I want to know what you guys think. I know, is it too late to get in? This bad boy is on fire. Could potentially be the cure for Americans. What do you guys think? Comment down below. Share the video everywhere. Here it is. I know. What do you guys think? It's been absolutely on fire. Screaming. Does this continue? If you think so, smash the like button. Comment down below. Give me a video everywhere. If I win and you win, we all win. It's true. It's your board rich. You're rich to be live. If you're not winning, you're not watching. We bring the winners. And we bring them to you first. I'm old. Peace. And congratulations to Amanda because I know Amanda's holding. I know. Smart, smart, smart cookie. Are you holding I know? Let's just blow this up. Hold on. Blow this up. Blow it up. It went up 69% today and is up 9.4% after market. What do you guys think? Comment down below. I want to know what you guys think. Your board rich, you're rich to be live. It's trying to bring you guys the winners, man. I try to bring it to you first. I always try to bring it to you first. It's true. What do you think? I know. Peace. Bye. Bye.